Ana-Maria Orbai

51PUBLICATIONS
98CO-AUTHORS
PharmacogenomicsPsychology of ageingMedical genetics (excl. cancer genetics)Toxicology (incl. clinical toxicology)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|May 19, 2026
Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

|Aug 05, 2025
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024.

Andre L Ribeiro, Tommy Kok Annfeldt, Dafna D Gladman

|Jul 14, 2025
Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma.

Ji Soo Kim, John Scott, Lauren Fisher

|Apr 07, 2025
Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies.

Philip J Mease, Lianne S Gensler, Ana-Maria Orbai

|Jan 15, 2025
Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic Arthritis.

Sarah M Yazji, Philip S Helliwell, Andra Balanescu

|Jan 03, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study.

Clementina López-Medina, Clémence Gorlier, Ana-Maria Orbai

Pageof 9

Frequent Collaborators

20 joint publications

Laura C Coates

19 joint publications

Ying-Ying Leung

18 joint publications

Dafna Gladman

15 joint publications

Alexis Ogdie